PHLEBOVIRUS RIFTENSE STRAIN ZH548 M12
UNII U79R7WQD7E

Substance Identification & Data

This profile provides standardized clinical and technical data for Phlebovirus Riftense Strain Zh548 M12, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U79R7WQD7E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U79R7WQD7E
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PHLEBOVIRUS RIFTENSE STRAIN ZH548 M12
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Phlebovirus Riftense Strain Zh548 M12. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

RIFT VALLEY FEVER VIRUS (STRAIN ZH-548 M12)
RVFV WILD-TYPE STRAINS ZH548 M12 (GENERATED BY SERIAL PLAQUE PASSAGES OF PARENTAL STRAIN ZH548 12 TIMES IN MRC-5 CELLS IN THE PRESENCE OF A CHEMICAL MUTAGEN, 5-FLUOROURACIL. AS A RESULT, MP-12 ENCODED 4, 9, AND 10 MUTATIONS IN THE S, M, AND L SEGMENTS, RESPECTIVELY. AMONG THEM, MUTATIONS IN THE M AND L SEGMENTS WERE RESPONSIBLE FOR ATTENUATION, WHILE THE MP-12 S SEGMENT STILL ENCODED A VIRULENT PHENOTYPE. AMPLIFICATION IS DONE IN MRC-5 CELLS WITHOUT 5-FLUOROURACIL)

Systematic Nomenclature

PHLEBOVIRUS RIFTENSE (ZH548 M12 STRAIN)
PHLEBOVIRUS RIFTENSE STRAIN ZH548 M12

Technical Codes

TSI-GSD-223